Table 2.
Glycemic index | Group (Number)a | Number of Study | Pooled SMD (95% CI) | Model | Heterogeneity assessment | ||
---|---|---|---|---|---|---|---|
I2 | Q test | P value | |||||
FPG | I = 275 | 9 | −0.03(−0.4,0.34) | Random | 78.4% | 37.10 | <0.001 |
P = 260 | |||||||
Insulin | I = 256 | 9 | −0.23(−0.6,0.14) | Random | 76.6% | 34.22 | <0.001 |
P = 243 | |||||||
HOMA-IR | I = 206 | 7 | −0.3(−0.82,0.22) | Random | 84.8% | 39.56 | <0.001 |
P = 201 | |||||||
HOMA-B | I = 130 | 4 | −0.63(−0.89,-0.38)* | Fixed | 0% | 1.23 | 0.75 |
P = 130 | |||||||
QUIKI | I = 130 | 4 | 0.74(0.49,0.1)* | Fixed | 0% | 0.53 | 0.91 |
P = 130 | |||||||
HbA1c | I = 96 | 3 | 0.1(−0.63,0.84) | Random | 83.1% | 11.85 | 0.003 |
P = 82 | |||||||
Adiponectin | I = 465 | 4a | 0.04 (−0.09,0.17) | Fixed | 0% | 0.40 | 0.94 |
P = 406 |
I Intervention group, C Control group, FPG fasting plasma glucose, HOMA-IR homeostasis model of assessment-estimated insulin resistance, HOMA-B homeostasis model of assessment-estimated b cell function, QUICKI quantitative insulin sensitivity check index, HbA1c hemoglobin A1c
a In one study, three different doses of adiponectin were used and we considered it as three studies
*Statistically significant